Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cosciens Biopharma Corp. sell Lokrim

Start price
€3.00
17.03.25 / 20%
Target price
-
17.03.26
Performance (%)
-72.33%
End price
€0.83
18.03.26
Summary
This prediction ended on 18.03.26 with a price of €0.83. Lokrim correctly predicted massive losses of -72.33% for Cosciens Biopharma Corp.. Lokrim has a follow-up prediction for Cosciens Biopharma Corp. where he still thinks Cosciens Biopharma Corp. is a Sell. Lokrim has 20% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Cosciens Biopharma Corp. -6.748% -6.748% -37.190%
iShares Core DAX® 0,79 % 1,97 % 13,39 %
iShares Nasdaq 100 4,23 % 4,34 % 39,72 %
iShares Nikkei 225® 3,29 % 6,99 % 49,89 %
iShares S&P 500 2,50 % 2,76 % 30,23 %

According to Lokrim what are the pros and cons of Cosciens Biopharma Corp. for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment
Growths slower than the competition

Comments by Lokrim for this prediction

In the thread Cosciens Biopharma Corp. diskutieren

Sell Cosciens Biopharma Corp.

In the thread Trading Cosciens Biopharma Corp.
Prediction Sell
Perf. (%) -72.33%
Target price
Change
Ends at 17.03.26

Die von Lokrim gewählte maximale Laufzeit wurde überschritten

Current prediction by Lokrim for Cosciens Biopharma Corp.

Cosciens Biopharma Corp.

Start price
Target price
Perf. (%)
€1.46
13.04.26
-
13.04.27
3.42%
16.04.26

Probably not worthwhile Investment
Growths slower than the competition